Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
نویسندگان
چکیده
منابع مشابه
Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
Nanoparticles have been making their way in biomedical applications and personalized medicine, allowing for the coupling of diagnostics and therapeutics into a single nanomaterial-nanotheranostics. Gold nanoparticles, in particular, have unique features that make them excellent nanomaterials for theranostics, enabling the integration of targeting, imaging and therapeutics in a single platform, ...
متن کاملPostconditioning: from experimental proof to clinical concept.
The therapeutic strategies for acute myocardial infarction in the last decade have, among other therapeutic targets, focused on myocardial reperfusion injury, which accounts for a significant part of the final infarct size. Although several experiments in the last 20 years have reported that pharmacological interventions at reperfusion might reduce myocardial reperfusion injury, this could not ...
متن کاملStroke centers: proof of concept and the concept of proof.
See related article, pages 1102–1107. If we could magically go into the future approximately 50 years, I suspect we would look back at the current time with fond memories. I say this because we may now be living through the “Golden Era” of stroke care. Over the past 10 to 20 years, there have been several major advances in the care of patients with cerebrovascular disease. These include the abi...
متن کاملTuroctocog alfa (NovoEight®) – from design to clinical proof of concept
Turoctocog alfa (NovoEight®) is a recombinant factor VIII (rFVIII) with a truncated B-domain made from the sequence coding for 10 amino acids from the N-terminus and 11 amino acids from the C-terminus of the naturally occurring B-domain. Turoctocog alfa is produced in Chinese hamster ovary (CHO) cells without addition of any human- or animal-derived materials. During secretion, some rFVIII mole...
متن کاملMyocardial Viability: From Proof of Concept to Clinical Practice
Ischaemic left ventricular (LV) dysfunction can arise from myocardial stunning, hibernation, or necrosis. Imaging modalities have become front-line methods in the assessment of viable myocardial tissue, with the aim to stratify patients into optimal treatment pathways. Initial studies, although favorable, lacked sufficient power and sample size to provide conclusive outcomes of viability assess...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nanomaterials
سال: 2015
ISSN: 2079-4991
DOI: 10.3390/nano5041853